Estimating the costeffectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa

dc.article.end-page15en
dc.article.start-page1en
dc.citation.doi10.1186/S12916-023-02806-Wen
dc.contributor.authorKoltai Mihalyen
dc.contributor.authorJocelyn Moyesen
dc.contributor.authorBryan Nyawandaen
dc.contributor.authorJoyce Nyiroen
dc.contributor.authorPatrick Munywokien
dc.contributor.authorStefano Tempiaen
dc.contributor.authorCheryl Cohenen
dc.contributor.authorE et alen
dc.date.accessioned2024-07-23T05:59:14Z
dc.date.available2024-07-23T05:59:14Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1741-7015en
dc.identifier.urihttps://hdl.handle.net/10539/39458
dc.journal.titleEstimating the costeffectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africaen
dc.journal.volume21en
dc.publisherBIOMED CENTRAL LTDen
dc.titleEstimating the costeffectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africaen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Journal Article.pdf
Size:
1.25 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client